Association of Event-Free and Distant Recurrence-Free Survival with Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial

Douglas Yee, Angela M. Demichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain, Yunn Yi Chen, Gregor Krings, Shi Wei, Shuko Harada, Brian Datnow, Oluwole Fadare, Molly Klein, Stefan Pambuccian, Beiyun Chen, Kathi Adamson, Sharon Sams, Paulette Mhawech-Fauceglia, Anthony Magliocco, Mike FeldmanMara Rendi, Husain Sattar, Jay Zeck, Idris T. Ocal, Ossama Tawfik, Lauren Grasso Lebeau, Sunati Sahoo, Tuyethoa Vinh, A. Jo Chien, Andres Forero-Torres, Erica Stringer-Reasor, Anne M. Wallace, Lajos Pusztai, Judy C. Boughey, Erin D. Ellis, Anthony D. Elias, Janice Lu, Julie E. Lang, Hyo S. Han, Amy S. Clark, Rita Nanda, Donald W. Northfelt, Qamar J. Khan, Rebecca K. Viscusi, David M. Euhus, Kirsten K. Edmiston, Stephen Y. Chui, Kathleen Kemmer, John W. Park, Minetta C. Liu, Olufunmilayo Olopade, Brian Leyland-Jones, Debasish Tripathy, Stacy L. Moulder, Hope S. Rugo, Richard Schwab, Shelly Lo, Teresa Helsten, Heather Beckwith, Patricia Haugen, Nola M. Hylton, Laura J. Van'T Veer, Jane Perlmutter, Michelle E. Melisko, Amy Wilson, Garry Peterson, Adam L. Asare, Meredith B. Buxton, Melissa Paoloni, Julia L. Clennell, Gillian L. Hirst, Ruby Singhrao, Katherine Steeg, Jeffrey B. Matthews, Smita M. Asare, Ashish Sanil, Scott M. Berry, Laura J. Esserman, Donald A. Berry

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint Dive into the research topics of 'Association of Event-Free and Distant Recurrence-Free Survival with Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences